Article Details

FDA approval of Argenx neuromuscular disease therapy is first in new drug class - MedCity News

Retrieved on: 2021-12-19 18:00:11

Tags for this article:

Click the tags to see associated articles and topics

FDA approval of Argenx neuromuscular disease therapy is first in new drug class - MedCity News. View article details on hiswai:

Excerpt

Alexion's antibody drug works in a different way, binding to the complement system protein C5 in order to block the immune response that develops in ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up